The 36-month beta value for LXRX is also noteworthy at 1.09. There are mixed opinions on the stock, with 1 analysts rating it as a
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)’s stock price has increased by 1.84 compared to its previous closing price of 0.68. However, the company has seen a
LXRX has 36-month beta value of 1.02. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,”
The stock of Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) has increased by 14.07 when compared to last closing price of 0.51. Despite this, the company has
Company’s 36-month beta value is 1.10.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 3 as
The stock of Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) has increased by 15.78 when compared to last closing price of 0.42. Despite this, the company has
Lexicon Pharmaceuticals Inc (NASDAQ: LXRX)’s stock price has increased by 64.13 compared to its previous closing price of 0.35. However, the company has seen a
In the past week, LXRX stock has gone down by -0.67%, with a monthly decline of -49.15% and a quarterly plunge of -50.65%. The volatility
© 2024, Powered by Smart TechOne
